Amdocs (NASDAQ:DOX) Director La Vega Rafael De Buys 2,297 Shares of Stock

Amdocs Limited (NASDAQ:DOX – Get Free Report) Director La Vega Rafael De purchased 2,297 shares of Amdocs stock in a transaction on Thursday, November 12th. The shares were acquired at an average cost of $44.51 per share, for a total transaction of $102,239.47. Following the completion of the transaction, the director owned 38,191 shares of the company’s stock, valued at $1,699,881.41. This represents a 6.40% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Amdocs Price Performance

DOX opened at $44.79 on Monday. Amdocs Limited has a 52-week low of $39.96 and a 52-week high of $84.95. The company has a 50 day moving average of $57.51 and a two-hundred day moving average of $60.98. The company has a market cap of $4.84 billion, a P/E ratio of 9.59, a P/E/G ratio of 1.46 and a beta of 0.42. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, meeting the consensus estimate of $1.98. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same quarter in the previous year, the business posted $1.83 EPS. The business’s quarterly revenue was up 3.8% on a year-over-year basis. On average, analysts expect that Amdocs Limited will post 5.82 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a $0.5690 dividend. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. Amdocs’s dividend payout ratio is presently 48.82%.

Analysts Set New Price Targets

DOX has been the subject of a number of recent research reports. Stifel Nicolaus lowered their target price on Amdocs from $71.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday, November 4th. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Oppenheimer downgraded shares of Amdocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 23rd. Finally, Zacks Research lowered shares of Amdocs from a “hold” rating to a “strong sell” rating in a report on Monday, November 9th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Amdocs presently has a consensus rating of “Hold” and a consensus price target of $69.00.

Read Our Latest Research Report on DOX

Institutional Trading of Amdocs

Several institutional investors and hedge funds have recently added to or reduced their stakes in DOX. Entropy Technologies LP acquired a new stake in Amdocs during the 3rd quarter worth about $2,916,000. Flputnam Investment Management Co. purchased a new position in shares of Amdocs in the third quarter worth approximately $1,889,000. Empowered Funds LLC increased its position in shares of Amdocs by 16.4% in the third quarter. Empowered Funds LLC now owns 62,097 shares of the technology company’s stock worth $3,551,000 after acquiring an additional 8,761 shares in the last quarter. Bleakley Financial Group LLC raised its holdings in shares of Amdocs by 29.4% during the third quarter. Bleakley Financial Group LLC now owns 23,272 shares of the technology company’s stock valued at $1,331,000 after acquiring an additional 5,289 shares during the period. Finally, First Trust Advisors LP raised its holdings in shares of Amdocs by 18.7% during the third quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company’s stock valued at $93,652,000 after acquiring an additional 258,098 shares during the period. 92.02% of the stock is owned by institutional investors and hedge funds.

About Amdocs

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Featured Stories

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.